Biotech Values

[DewDiligence]

PVMP IPOs 13.53M* shares @$18.00:

https://www.globenewswire.com/news-release/2020/09/25/2099064/0/en/PMV-Pharma-Announces-Pricing-of-Initial-Public-Offering.html

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. …PMV Pharma is headquartered in Cranbury, New Jersey.

Whenever I see p53 mentioned in a biotech company’s business plan, I feel like I’m in a time warp.

*Assuming exercise of underwriter’s option.